Your browser doesn't support javascript.
loading
Reprogramming neuroblastoma by diet-enhanced polyamine depletion.
Cherkaoui, Sarah; Yang, Lifeng; McBride, Matthew; Turn, Christina S; Lu, Wenyun; Eigenmann, Caroline; Allen, George E; Panasenko, Olesya O; Zhang, Lu; Vu, Annette; Liu, Kangning; Li, Yimei; Gandhi, Om H; Surrey, Lea; Wierer, Michael; White, Eileen; Rabinowitz, Joshua D; Hogarty, Michael D; Morscher, Raphael J.
Afiliação
  • Cherkaoui S; Pediatric Cancer Metabolism Laboratory, Children's Research Center, University of Zurich, 8032 Zurich, Switzerland.
  • Yang L; Division of Oncology, University Children's Hospital Zurich and Children's Research Center, University of Zurich, 8032 Zurich, Switzerland.
  • McBride M; Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
  • Turn CS; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ 08544, USA.
  • Lu W; Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
  • Eigenmann C; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ 08544, USA.
  • Allen GE; Division of Oncology and Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Panasenko OO; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Zhang L; Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
  • Vu A; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ 08544, USA.
  • Liu K; Pediatric Cancer Metabolism Laboratory, Children's Research Center, University of Zurich, 8032 Zurich, Switzerland.
  • Li Y; Division of Oncology, University Children's Hospital Zurich and Children's Research Center, University of Zurich, 8032 Zurich, Switzerland.
  • Gandhi OH; Bioinformatics Support Platform, Faculty of Medicine, University of Geneva 1211, Switzerland.
  • Surrey L; Department of Microbiology and Molecular Medicine, Institute of Genetics and Genomics Geneva, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
  • Wierer M; Department of Microbiology and Molecular Medicine, Institute of Genetics and Genomics Geneva, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
  • White E; BioCode: RNA to proteins (R2P) Platform, University of Geneva, 1211 Geneva, Switzerland.
  • Rabinowitz JD; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ 08544, USA.
  • Hogarty MD; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08901, USA.
  • Morscher RJ; Department of Molecular Biology and Biochemistry, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
bioRxiv ; 2024 Jan 08.
Article em En | MEDLINE | ID: mdl-38260457
ABSTRACT
Neuroblastoma is a highly lethal childhood tumor derived from differentiation-arrested neural crest cells1,2. Like all cancers, its growth is fueled by metabolites obtained from either circulation or local biosynthesis3,4. Neuroblastomas depend on local polyamine biosynthesis, with the inhibitor difluoromethylornithine showing clinical activity5. Here we show that such inhibition can be augmented by dietary restriction of upstream amino acid substrates, leading to disruption of oncogenic protein translation, tumor differentiation, and profound survival gains in the TH-MYCN mouse model. Specifically, an arginine/proline-free diet decreases the polyamine precursor ornithine and augments tumor polyamine depletion by difluoromethylornithine. This polyamine depletion causes ribosome stalling, unexpectedly specifically at adenosine-ending codons. Such codons are selectively enriched in cell cycle genes and low in neuronal differentiation genes. Thus, impaired translation of these codons, induced by the diet-drug combination, favors a pro-differentiation proteome. These results suggest that the genes of specific cellular programs have evolved hallmark codon usage preferences that enable coherent translational rewiring in response to metabolic stresses, and that this process can be targeted to activate differentiation of pediatric cancers.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article